TOBIN JAMES R sold $385K of TMDX
TOBIN JAMES R sold 4,059 shares of TransMedics Group, Inc. (TMDX) at an average of $94.97 ($93.96–$94.98, $0.39M total) across 2 trades on 2026-11-09.
How this was made
The 30-second read
Why it matters
Director's sale may be interpreted as a slight negative signal, but size is modest.
Market read
Small insider sale with limited market impact; primarily of interest to short‑term traders monitoring insider activity.
What to watch
Potential upcoming corporate actions or financing needs not disclosed in the filing.
Background
SEC Form 4 filing discloses insider transactions required by regulation.
Ticker impact
Director Tobin James R sold 4,059 shares of TransMedics Group for $385K via open‑market transactions on 2026‑11‑09.
potential modest pressure as the market prices in the director's share disposal
A director selling a few thousand shares at near $95 each is a small but material signal; investors may view it as a negative cue.
Market effects
Limited impact on the broader medical device sector; insider sales are company‑specific.
No significant regional effect; confined to TransMedics shareholders.
Minimal global relevance; isolated insider transaction.
Counterpoint
The sale could be routine liquidity need and not indicative of future performance.
Key entities
- companyTransMedics Group, Inc.
US‑listed medical device company (ticker TMDX).
- personTobin James R
Director of TransMedics Group.



